Two Sigma Advisers’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-83,600
| Closed | -$12.2M | – | 2851 |
|
|
2022
Q2 | $12.2M | Sell |
83,600
-1,600
| -2% | -$233K | 0.03% | 455 |
|
|
2022
Q1 | $10.1M | Buy |
85,200
+37,400
| +78% | +$4.43M | 0.03% | 520 |
|
|
2021
Q4 | $6.59M | Buy |
47,800
+8,900
| +23% | +$1.23M | 0.02% | 652 |
|
|
2021
Q3 | $5.4M | Buy |
+38,900
| New | +$5.4M | 0.01% | 749 |
|
|
2021
Q2 | – | Sell |
-24,430
| Closed | -$1.67M | – | 2846 |
|
|
2021
Q1 | $1.67M | Sell |
24,430
-52,700
| -68% | -$3.6M | ﹤0.01% | 1361 |
|
|
2020
Q4 | $6.61M | Sell |
77,130
-63,100
| -45% | -$5.41M | 0.02% | 720 |
|
|
2020
Q3 | $9.12M | Buy |
140,230
+23,600
| +20% | +$1.53M | 0.03% | 565 |
|
|
2020
Q2 | $8.53M | Sell |
116,630
-51,500
| -31% | -$3.77M | 0.03% | 604 |
|
|
2020
Q1 | $5.72M | Sell |
168,130
-136,100
| -45% | -$4.63M | 0.02% | 662 |
|
|
2019
Q4 | $16.6M | Buy |
304,230
+43,200
| +17% | +$2.35M | 0.04% | 440 |
|
|
2019
Q3 | $10.9M | Buy |
261,030
+70,100
| +37% | +$2.92M | 0.03% | 517 |
|
|
2019
Q2 | $8.36M | Buy |
190,930
+89,300
| +88% | +$3.91M | 0.02% | 645 |
|
|
2019
Q1 | $5.23M | Buy |
101,630
+84,800
| +504% | +$4.36M | 0.01% | 823 |
|
|
2018
Q4 | $622K | Buy |
+16,830
| New | +$622K | ﹤0.01% | 1683 |
|